Navigation Links
Equinoxo2 Medical Announces Distribution of a New Portable Device
Date:7/17/2012

SMITHFIELD, R.I., July 17, 2012 /PRNewswire-iReach/ -- Smithfield, RI-July 17, 2012 EquinoxO2 Medical, LLC, developer of negative pressure wound therapy (NPWT) foam dressings and pump systems, announced today development and distribution of its HALO XP npwt pump system, Part#  HXP2000. The HALO XP was designed for ambulatory patients. It's a light weight and portable system that combines advanced technology with easy-to-use features. The new portable npwt pump was created to provide an affordable option to patients and healthcare facilities.

(Photo: http://photos.prnewswire.com/prnh/20120717/CG41947)

Chronic, non healing or untreated wounds are clinically affecting many patients and adding significant cost to our healthcare system. This cost is estimated at $113 billion. This medical cost will continue to increase even with competitive bidding starting by the end of 2012.  Equinox believes that affordable npwt technology should be available to all chronic patients. "We are very proud to offer patients and clinicians the HALO XP Pump System, the latest offering in our expanding npwt product portfolio for the successful treatment of all chronic wounds and affordable access to negative pressure therapy." said Rian Mallari, president and chief executive officer, EquinoxO2 Medical, LLC.

About EquinoxO2 Medical, LLC

Equinoxo2 Medical, LLC, headquartered in Smithfield, RI is a privately held medical device company focused on the development of advanced wound healing technology. Equinox is dedicated to developing and designing innovative wound care products that are cost effective and deliver significant clinical outcomes. Our goal and strategy is to improve a patient's quality of life. Our passion and dedication is to provide a better solution in repairing and healing the human body. For more information, please visit www.equinoxo2.com.

Media Contact
Gary Schear
800-504-3150 Ext 3
Gary@equinoxo2.com

Media Contact: Rian Mallari EquinoxO2 Medical, LLC, 800-504-3150 Ext 1, rian@equinoxo2.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE EquinoxO2 Medical, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... Sept. 7, 2017  For nearly two decades, New Life Agency has ... Reproduction Insurance industry. Today, New Life Agency announces a powerful three-way partnership ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/7/2017)...   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade cell and tissue hypothermic storage and ... , President and CEO, will be presenting at two investment ... Renshaw 19 th Annual Global Investment Conference on Tuesday, ... time). The conference is being held at the New York ...
(Date:9/6/2017)... , Sept. 6, 2017 NeuroRx, a clinical ... Suicidal Ideation and Behavior (ASIB), has been granted Fast Track ... sequential therapy of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine ... a pivotal trial of this sequential therapy targeting patients who ... 1 ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... ... setbacks, a senior finds a new lease on life with assistance from CreditAssociates. ... people resolve their problem with unsecured debt. The senior is one of the ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... on the fallacy of an obligatory tithe, and the freedom experienced when breaking ... the creation of published author, Lysa M. Harrison. , Published by Christian Faith ...
(Date:9/22/2017)... ... ... “Fruit of the Spirit: “Love””: a delightful adventure of two friends who ... the Spirit: “Love”” is the creation of published author, Halimah Jones, who was born ... is an avid writer, her inspiration for “Fruit of the Spirit: “Love”” blossomed from ...
(Date:9/21/2017)... Aliso Viejo, CA (PRWEB) , ... September 21, 2017 , ... ... never been so fun and easy to do. Users can select from up to ... more all with a click of a mouse all within Final Cut Pro ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional Communication:, Keeping Up ... , In the competitive world of drug and device marketing and promotion, drug ... FDA rules. , The FDA has issued two draft guidances that are the ...
Breaking Medicine News(10 mins):